Recurrent Ovarian Germ Cell Tumor Terminated Phase Trials for Motexafin lutetium (DB05296)

IndicationStatusPhase
DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00087191EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerDiagnostic